Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Common Equity (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Common Equity for 15 consecutive years, with $186.7 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 20.28% to $186.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $186.7 million through Dec 2025, up 20.28% year-over-year, with the annual reading at $159.8 million for FY2025, 9.93% up from the prior year.
  • Common Equity hit $186.7 million in Q4 2025 for Mesa Laboratories, up from $178.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $406.2 million in Q1 2021 to a low of $145.4 million in Q1 2024.
  • Historically, Common Equity has averaged $300.9 million across 5 years, with a median of $383.8 million in 2022.
  • Biggest five-year swings in Common Equity: soared 84.64% in 2021 and later plummeted 63.05% in 2024.
  • Year by year, Common Equity stood at $396.3 million in 2021, then decreased by 2.3% to $387.2 million in 2022, then grew by 4.07% to $403.0 million in 2023, then crashed by 61.48% to $155.2 million in 2024, then grew by 20.28% to $186.7 million in 2025.
  • Business Quant data shows Common Equity for MLAB at $186.7 million in Q4 2025, $178.5 million in Q3 2025, and $172.5 million in Q2 2025.